胆作为乳牛产期疾病的调节剂
Fenghong Wang1, Yuanyin Guo2, Xiu Su3
1Sano (Yangling) Modern Animal Nutrition Co., Ltd., Yangling 712199, China.
Veterinary sciences
|October 28, 2025
概括
乳液保护胆 (RPC) 补充剂通过改善脂质代谢和减少炎症来减轻奶牛的负能量平衡 (NEB). 这在关键的过渡期内支持牛的健康和生产力.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 动物营养 动物营养
- 代谢疾病 代谢疾病
背景情况:
- 负能量平衡 (NEB) 的奶牛面临的是代谢和炎症问题,如症和乳腺炎.
- NEB破坏脂质代谢,增加脂肪酸的合成和积累,并损害免疫功能.
研究的目的:
- 为了研究反保护胆 (RPC) 对乳牛中NEB诱导的代谢和炎症疾病的影响.
- 阐明RPC改善脂质代谢和免疫反应的分子机制.
主要方法:
- 该研究分析了NEB对脂质代谢标记物,氧化应激和炎症性细胞因子的影响.
- 研究了参与脂质合成,出口和氧化的分子途径.
- 评估了RPC对这些参数和免疫细胞功能的影响.
主要成果:
- 通过调节关键蛋白质,RPC补充改善了非常低密度脂蛋白 (VLDL) 组合和三糖醇 (TAG) 出口.
- RPC增强了脂肪酸氧化,减少了氧化和内质网膜压力.
- RPC降低了炎症标志物 (IL-6,TNF-α) 和改善了多态核中性粒细胞 (PMN) 功能.
结论:
- 在乳牛中,RPC有效地缓解了NEB诱导的代谢功能障碍和炎症.
- RPC支持脂质代谢,减少氧化应激,增强免疫防御.
- RPC是周周的奶牛管理NEB和相关疾病的宝贵营养策略.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.6K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.6K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.2K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Synthesis of Phosphatidylcholine in the ER Membrane
4.0K
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
4.0K


